Published in:
01-08-2011 | Editorial
Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents
Authors:
Guy Sisson, Ingvar Bjarnason
Published in:
Inflammopharmacology
|
Issue 4/2011
Login to get access
Excerpt
The use of non-steroidal anti-inflammatory drugs (NSAIDs) is steadily increasing. The main concerns with this class of drugs are the frequency and severity of their gastrointestinal side effects (Hayllar et al.
1992). This is particularly so now that the focus on their adverse cardiovascular effects, especially with the cyclo-oxygenase (COX)-2 selective agents, seems to be waning. …